1. 李校堃 中国 温州医科大学 中国工程院院士 The nonalcoholic fatty liver risk in prediction of unfavorable outcome after stroke: A nationwide re..
2. Walter C,Willett 美国 Harvard School of Public Health 1998美国医学院院士 Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality..
3. 王广基 中国 中国药科大学 中国工程院院士 Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
4. 庄辉 中国 北京大学 中国工程院院士 Guidelines of prevention and treatment of nonalcoholic fatty liver disease[2018, China]
5. Bruce D,Hammock 美国 University of California Davis 1999美国科学院院士 Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis b..
6. Giorgio,Minotti 意大利 University of Campus Biomed Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
7. Ioanna,Andreadou 希腊 University of ATHENS Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
8. Gianluigi,Savarese 瑞典 Karolinska Institute Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
9. Dobromir,Dobrev 德国 University of Duisburg-Essen Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
10. Filippo,Crea 意大利 University of Cattolica Sacro Cuore Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
11. Kaski, Juan C 英国 St George’s, University of London Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
12. Rudolf A,de Boer 荷兰 University of Groningen Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
13. Peter,Ferdinandy 匈牙利 Semmelweis University Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
14. Lin, Jiandie D. 美国 University of Michigan Neuregulin 4 mediates the metabolic benefits of mild cold exposure by promoting beige fat thermogene..
15. 陈得源 中国 台湾中国医药大学 Increased NAFLD risk in newly diagnosed patients with RA during the first 4 years of follow-up: a na..
16. Zobair M,Younossi 美国 Inova Fairfax Hospital Lifestyle interventions in nonalcoholic fatty liver disease
17. Shira,Zelber-Sagi 以色列 University of Haifa Lifestyle interventions in nonalcoholic fatty liver disease
18. Naveed,Sattar 英国 University of Glasgow Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit..
19. Hashem B,El-Serag 美国 Baylor College of Medicine Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT st..
20. Paul Michael,Yen 新加坡 杜克-新加坡国立大学医学院 Reply to: "Hyperhomocysteinemia predicts liver-related clinical outcomes in the general population"